DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit

Information source: University of Pittsburgh
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gram-negative Bacterial Infections

Phase: N/A

Status: Active, not recruiting

Sponsored by: University of Pittsburgh

Official(s) and/or principal investigator(s):
David Paterson, MD, Principal Investigator, Affiliation: University of Pittsburgh

Summary

The proposed endpoints of the study would be: comparative use of piperacillin versus broader spectrum agents (e. g., piperacillin/tazobactam, etc.) [measured as defined daily doses per 1000 patient days]; physician acceptance of piperacillin as part of a streamlining program [measured as successful occurrences of the use of piperacillin as streamlining therapy]; changes in susceptibility patterns of broad spectrum antibiotics [measured as % Gram negative bacilli susceptible to each of the commonly used broad spectrum antibiotics]; and outcome of patients treated with streamlined therapy.

Clinical Details

Official title: Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit

Study design: Time Perspective: Retrospective

Primary outcome: dead or alive

Detailed description: The following variables will be followed: time and location of positive cultures, underlying diseases and severity of illness, recent immunomodulative therapies, physical exam findings, laboratory and radiographical data, antimicrobial usage, microbiological data and resistance patterns, choice of antibiotics once organism is identified, suspected source of infection, bacteriological outcomes, laboratory results, demographic information, medications, clinical outcome, gender, height, weight, ethnicity, and past medical history.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients with Gram negative infections treated with piperacillin/tazobactam and/or

piperacillin

Locations and Contacts

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, United States
Additional Information

Starting date: September 2005
Last updated: December 5, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017